Zooming in on Cardiovascular Risk Control With Glucagon-Like Peptide-1 Receptor Agonists in Diabetes

Are you up to date with the latest research and recommendations for cardiometabolic risk? Join Dr Kim Connelly for insights from ESC 2021. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/962202?src=mkm_podcast_addon_962202